We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Linda Barbour

Linda A. Barbour MD, MSPH, FACP

Professor, Divisions of Endocrinology, Metabolism and Diabetes and Maternal-Fetal Medicine, University of Colorado School of Medicine, Anschutz Medical Campus, Aurora, Colorado

Dr. Barbour is a Tenured Professor in Endocrinology, Metabolism and Diabetes and Maternal-Fetal Medicine with a Master’s of Science in Public Health. Her clinical and research expertise are in endocrine and metabolic diseases in pregnancy and she is the Director of the OB Diabetes Clinic and High-Risk OB Clinics at University Hospital. She oversees the care of nearly all women with Type 1 and Type 2 diabetes at University Hospital as well as at Denver Health and Hospital. She was awarded the Norbert Freinkel award in 2018 by the ADA for her teaching, clinical and research contributions to advance the care of pregnant women with diabetes and metabolic disease and recently received an ADA Innovative Clinical/Translational Grant for her research on the role of maternal lipids as a contributor to excess fetal growth. She is on the Editorial Board for “Diabetes Care”, Past Chair for the ADA Scientific Planning Committee for Pregnancy, served on the NIH Research Panel on Gestational Diabetes, and serves as a Key Informant on the USPSTF on Screening for Gestational Diabetes. She has been named in “Best Doctors in America” for over 25 years, authored ~100 manuscripts, chapters, or textbooks. Her clinical/translational research has been funded by NIH K23, R21, R01 and ADA grants, and she has served as a research mentor for over 30 junior investigators in the study of the intrauterine environment and fetal programming of childhood obesity and metabolic disease.  

Disclosures

Dr. Barbour has no relevant disclosures.

Recent Contributions to PracticeUpdate:

  1. Metformin in Women With T2DM in Pregnancy